M

MWG Management Ltd. Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for MWG Management Ltd. with $81.3M in long positions as of Q3 2025, 100% allocated to Healthcare, and 100% concentrated in top 10 positions.

Portfolio Value
$81.3M
Top 10 Concentration
100%
Top Sector
Healthcare (100%)
US Exposure
100%
Market Cap Focus
Mid Cap
Countries
1

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 100.00%Healthcare
Healthcare
100.00%

Industry Breakdown

1 industry across all sectors

Biotechnology: 100.00%Biotechnology
Biotechnology
Healthcare
100.00%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mid Cap ($2B - $10B): 67.66%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 20.13%Small Cap ($300M - $2B)Nano Cap (< $50M): 12.21%Nano Cap (< $50M)
Mid Cap ($2B - $10B)
67.66%
Small Cap ($300M - $2B)
20.13%
Nano Cap (< $50M)
12.21%

Portfolio Concentration

Top 10 Holdings %
100.0%
Top 20 Holdings %
100.0%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
100.0%
International
-
Countries
1
United States of America
100.00% ($81.3M)
3 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
15.7 quarters
Avg. Top 20
15.7 quarters
Avg. All Positions
15.7 quarters
Median Holding Period
17 quarters
Persistence Rate
100.0%
Persistent Holdings Weight
100.0%
Persistent Positions
3
Longest Held
Beam Therapeutics Inc. Common Stock logo
Beam Therapeutics Inc. Common StockBEAM - 19 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.000%
Avg. Position Weight
33.33%
Largest Position
Beam Therapeutics Inc. Common Stock logo
Beam Therapeutics Inc. Common StockBEAM - 67.66%
Largest Ownership Stake
Lyell Immunopharma, Inc. Common Stock logo
Lyell Immunopharma, Inc. Common StockLYEL - 5.25%
Avg. Ownership Stake
2.57%
Ownership Stake >5%
1
Ownership Stake >1%
2

Historical (Since Q4 2020)

Avg. New Position
38.09%
Avg. Ownership Stake
5.16%
Largest Position
Beam Therapeutics Inc. Common Stock logo
Beam Therapeutics Inc. Common StockBEAM - 94.48% (Q4 2020)
Largest Ownership Stake
Lyell Immunopharma, Inc. Common Stock logo
Lyell Immunopharma, Inc. Common StockLYEL - 8.45% (Q2 2021)

Portfolio Turnover

Current Quarter

Turnover Ratio
0.0%
Value Traded
$0.00
Positions Added
0
Positions Exited
0

Historical (Since Q4 2020)

Avg. Turnover Ratio
6.2%
Avg. Positions Added
0
Avg. Positions Exited
0
Highest Turnover
50.0%
Q4 2020

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.